The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells
Abstract
Chronic obstructive pulmonary disease is a highly prevalent, complex disease, usually caused by cigarette smoke. It causes serious morbidity and mortality and costs the global community billions of dollars per year. While chronic inflammation, extracellular matrix destruction and increased airway epithelial cell apoptosis are reported in chronic obstructive pulmonary disease, the understanding of the basic pathogenesis of the disease is limited and there are no effective treatments. We hypothesized that the accumulation of apoptotic airway epithelial cells chronic obstructive pulmonary disease in could be due to defective phagocytic clearance by alveolar macrophages. There have been no previous studies of the phagocytic capacity of alveolar macrophages in chronic obstructive pulmonary disease using physiologically relevant apoptotic airway epithelial cells as phagocytic targets. We developed a phagocytosis assay whereby cultured 16HBE airway epithelial cells were induced to apoptosis with ultraviolet radiation and stained with mitotracker green. Alveolar macrophages from bronchoalveolar lavage from eight control and six chronic obstructive pulmonary disease subjects were analysed following 1.5 h incubation with apoptotic airway epithelial cells, then staining with macrophage marker anti CD33. CD33+/mitotracker green + events (i.e., alveolar macrophages which had phagocytosed apoptotic airway epithelial cells) were analysed using flow cytometry. Phagocytosis of polystyrene microbeads was investigated in parallel. A significantly reduced proportion of alveolar macrophages from chronic obstructive pulmonary disease subjects ingested apoptotic airway epithelial cells compared with controls (11.6 ± 4.1% for chronic obstructive pulmonary disease versus 25.6 ± 9.2% for control group). Importantly, the deficiency was not observed using polystyrene beads, suggesting that the failure to resolve epithelial damage in chronic obstructive pulmonary disease may result, at least partially, from specific defects in phagocytic ability of alveolar macrophages to ingest apoptotic airway epithelial cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Impaired phagocytosis and clearance of cellular debris by airway macrophages in COPD result in persistent inflammation (85, 104).”
From Aging and Lung Disease (2020) · cites this paper as [104]
In the citing paper
“Specifically, macrophages, which can produce multiple proinflammatory cytokines and secrete MMPs, are the most abundant cell type in the BAL fluid of COPD patients, and increased numbers correlate with disease severity (85, 86, 104).”
From Aging and Lung Disease (2020) · cites this paper as [104]
In the citing paper
“Due to reduced immunity, coexisting comorbidities, and age-associated functional limitations, the incidence of severe sepsis and septic shock increases in older individuals (104, 146).”
From Aging and Lung Disease (2020) · cites this paper as [104]
Citations
Cites
Disruption of epithelial cell-matrix interactions induces apoptosis
Frisch, S., & Francis, H. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.124.4.619 · Cited by 3,276
Inhibition of VEGF receptors causes lung cell apoptosis and emphysema
Kasahara, Y., Tuder, R. M., Taraseviciene‐Stewart, L., Cras, T. D. L., Abman, S. H., Hirth, P., Waltenberger, J. L., & Voelkel, N. F. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10259 · Cited by 1,113
Savill, J., Hogg, N., Ren, Y., & Haslett, C. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116019 · Cited by 818
Flow cytometry of apoptotic cell death
Vermes, I., Haanen, C., & Reutelingsperger, C. P. M. (2000) · Journal of Immunological Methods · doi:10.1016/s0022-1759(00)00233-7 · Cited by 808
Pauwels, R., Buist, A. S., Calverley, P., Jenkins, C. R., Hurd, S. S., & Lenfant, C. J. M. (2001) · Respiratory Care · doi:10.1177/002013240104600806 · Cited by 614
Segura-Valdéz, M. D. L., Pardo, A., Gaxiola, M., Uhal, B. D., Becerril, C., & Selman, M. (2000) · CHEST Journal · doi:10.1378/chest.117.3.684 · Cited by 507
Trautmann, A., Akdiş, M., Kleemann, D., Altznauer, F., Simon, H., Graeve, T., Noll, M., Bröcker, E., Blaser, K., & Akdiş, C. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9199 · Cited by 495
Fadok, V. A., Warner, M. L., Bratton, D. L., & Henson, P. M. (1998) · PubMed · Cited by 406
Vandivier, R. W., Fadok, V. A., Hoffmann, P. R., Bratton, D. L., Penvari, C., Brown, K. K., Brain, J. D., Accurso, F. J., & Henson, P. M. (2002) · Journal of Clinical Investigation · doi:10.1172/jci13572 · Cited by 373
Fadok, V. A., Warner, M. L., Bratton, D. L., & Henson, P. M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.11.6250 · Cited by 353
Research works printed but not linked: 1
- Gibson P, 1997, Pulmonary macrophage phagocytosis of apoptotic neutrophils is mediated by thrombospondin and its receptors‐avb3 and CD36, Am. J. Respir. Crit. Care Med., 155, A296
Cited by
Sorted by citations
Items 201–300 of 439
Molecular mechanisms of action of Trehalose in cancer: A comprehensive review
Chaitanya, N. S. N., Devi, A., Sahu, S., & Alugoju, P. (2021) · Life Sciences · doi:10.1016/j.lfs.2020.118968 · Cited by 37
Characterization of Mainstream Cigarette Smoke-Induced Biomarker Responses in ICR and C57Bl/6 Mice
Obot, C. J., Lee, K. M., Fuciarelli, A. F., Renne, R. A., & McKinney, W. J. (2004) · Inhalation Toxicology · doi:10.1080/08958370490476604 · Cited by 37
“For example, proteases released from inflammatory cells can impair apoptotic cell recognition and proper uptake by phagocytic cells (Henson et al., 2001; Hodge et al., 2003), which could contribute to chronic inflammation with eventual lung impairment (Vandivier et al.”
BackgroundWeen, M. P., Hamon, R., Macowan, M. G., Thredgold, L. D., Reynolds, P. N., & Hodge, S. J. (2019) · Respirology · doi:10.1111/resp.13696 · Cited by 36
Self-citationLiu, Y., Liu, H., Li, C., Ma, C., & Ge, W. (2020) · International Journal of COPD · doi:10.2147/copd.s246845 · Cited by 36
Monocytes Recruited to the Lungs of Mice during Immune Inflammation Ingest Apoptotic Cells Poorly
Jennings, J. H., Linderman, D. J., Hu, B., Sonstein, J., & Curtis, J. L. (2004) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2004-0108oc · Cited by 36
Sharma, L., Wu, W., Dholakiya, S. L., Gorasiya, S., Wu, J., Sitapara, R. A., Patel, V., Wang, M., Zur, M., Reddy, S., et al. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0928-5_12 · Cited by 40
Tran, H. B., Barnawi, J., Ween, M. P., Hamon, R., Roscioli, E., Hodge, G. L., Reynolds, P. N., Pitson, S. M., Davies, L. T., Haberberger, R. V., et al. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1015-471r · Cited by 35
“plots for the efferocytosis assay have been reported previously [4].”
BackgroundSelf-citationWootton, D. G., Dickinson, L., Pertinez, H. E., Court, J., Eneje, O., Keogan, L., Macfarlane, L., Wilks, S., Gallagher, J., Woodhead, M. A., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.02170-2016 · Cited by 35
“…during a hospital admission [13]; smoking, which impairs recovery mechanisms [14]; COPD, which is associated with an increased risk of pneumonia [15]; pro-calcitonin (PCT) level, which has been suggested to have prognostic value [16]; C-reactive protein (CRP) level, which has been associated…”
Apoptosis as a therapeutic target for the treatment of lung disease
de Souza, P. M., & Lindsay, M. A. (2005) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2005.01.012 · Cited by 34
Identification and clinical association of anti-cytokeratin 18 autoantibody in COPD
Kuo, Y., Chang, C. A., Wu, Y., Hsieh, M., Tsai, C.-H., Chen, K.-T., Chen, C.-Y., & Chan, E. (2009) · Immunology Letters · doi:10.1016/j.imlet.2009.12.017 · Cited by 34
Efferocytosis capacities of blood monocyte‐derived macrophages in systemic sclerosis
Ballerie, A., Lescoat, A., Augagneur, Y., Lelong, M., Morzadec, C., Cazalets, C., Jouneau, S., Fardel, O., Vernhet, L., Jégo, P., et al. (2018) · Immunology and Cell Biology · doi:10.1111/imcb.12217 · Cited by 34
Diesel Exhaust Particle Exposure In Vitro Alters Monocyte Differentiation and Function
Chaudhuri, N., Jary, H. R., Lea, S., Khan, N. U., Piddock, K. C., Dockrell, D. H., Donaldson, K., Duffin, R., Singh, D., Parker, L. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051107 · Cited by 34
“Indeed, alveolar macrophages from COPD individuals show reduced phagocytosis of apoptotic epithelial cells compared to non smokers [17] and monocyte derived macrophages (MDMs) from people with COPD also show reduced phagocytosis in response to pathogens [18].”
BackgroundPrix Fixe: Efferocytosis as a Four-Course Meal
Martinez, J. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_467 · Cited by 36
“Chronic inflammation, extracellular matrix destruction, and increased airway epithelial cell and neutrophil apoptosis are reported in COPD models, and alveolar macrophages from COPD patients demonstrate a decreased phagocytic capacity for apoptotic cells (Hodge et al. 2003).”
BackgroundHeulens, N., Korf, H., & Janssens, W. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.223032 · Cited by 33
“of apoptotic cells (“efferocytosis”) (Hodge et al., 2003; Kirkham et al., 2004; Hodge et al., 2007).”
BackgroundSingle-Cell Sequencing of Lung Macrophages and Monocytes Reveals Novel Therapeutic Targets in COPD
Hu, Y., Shao, X., Xing, L., Li, X., Nonis, G. M., Koelwyn, G. J., Zhang, X., & Sin, D. D. (2023) · Cells · doi:10.3390/cells12242771 · Cited by 34
Neutrophil extracellular traps and their implications in airway inflammatory diseases
Xuan, N., Zhao, J., Kang, Z.-Y., Cui, W., & Tian, B. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2023.1331000 · Cited by 32
“It has been suggested a significant reduction in the number of macrophages in sputum samples from COPD patients compared to normal controls, and the phagocytic function of surviving macrophages is also defective (87, 126).”
BackgroundThe transient but not resident (TBNR) microbiome: a Yin Yang model for lung immune system
Saeedi, P., Salimian, J., Ahmadi, A., & Fooladi, A. A. I. (2015) · Inhalation Toxicology · doi:10.3109/08958378.2015.1070220 · Cited by 31
Zarin, A. A., Behmanesh, M., Tavallaie, M., Shohrati, M., & Ghanei, M. (2010) · Experimental Lung Research · doi:10.3109/01902140903578868 · Cited by 32
The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD
Ween, M. P., White, J. B., Tran, H. B., Mukaro, V. R., Jones, C., Macowan, M. G., Hodge, G., Trim, P. J., Snel, M. F., & Hodge, S. J. (2021) · Scientific Reports · doi:10.1038/s41598-021-82481-0 · Cited by 31
Self-citationDefective apoptotic cell clearance in asthma and COPD – a new drug target for statins?
Walsh, G. M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.11.002 · Cited by 32
The impact of the immune system on lung injury and regeneration in COPD
Kapellos, T. S., Conlon, T. M., Yildirim, A. Ö., & Lehmann, M. (2023) · European Respiratory Journal · doi:10.1183/13993003.00589-2023 · Cited by 31
McCubbrey, A. L., Sonstein, J., Ames, T. M., Freeman, C. M., & Curtis, J. L. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200984 · Cited by 31
“It would be interesting to test whether increased immunosuppression from ACs within the lung may explain these opposing results between COPD patients and model systems regarding ICS use and pneumonia, particularly for emphysema patients where lung destruction generates large numbers of ACs.”
BackgroundInfluentialBioactive Sphingolipids in the Pathogenesis of Chronic Obstructive Pulmonary Disease
Koike, K., Berdyshev, E. V., Bowler, R. P., Scruggs, A. K., Cao, D., Schweitzer, K. S., Serban, K. A., & Petrache, I. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201809-592mg · Cited by 31
Role of Apoptotic Cell Clearance in Pneumonia and Inflammatory Lung Disease
Zheng, D. J., Taka, M. A., & Heit, B. (2021) · Pathogens · doi:10.3390/pathogens10020134 · Cited by 32
“Notably, inhaled corticosteroids—which are essential therapeutic agents for patients with COPD—were associated with increased cases of CAP.”
BackgroundInfluentialLiu, C., Li, P., Zheng, J., Wang, Y., Wu, W., & Liu, X. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01154-7 · Cited by 31
“However, the ability of alveolar macrophages to phagocytose apoptotic epithelial cells is impaired in COPD [43].”
BackgroundLee, Y.-J., Lee, S.-H., Youn, Y.-S., Choi, J.-Y., Song, K.-S., Cho, M.-S., & Kang, J. L. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.05.024 · Cited by 31
Airway Clearance of Apoptotic Cells in COPD
Mukaro, V. R., & Hodge, S. J. (2011) · Current Drug Targets · doi:10.2174/138945011794751609 · Cited by 30
“The results showed decreased CD31 expression on AM from healthy smokers and current smoker COPD subjects, who displayed defective efferocytosis [65, 66].”
BackgroundSelf-citationBarnawi, J., Tran, H. B., Roscioli, E., Hodge, G. L., Jersmann, H. P. A., Haberberger, R. V., & Hodge, S. J. (2016) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.3109/15412555.2016.1153614 · Cited by 29
“The cells were harvested as previously described (3), and frozen immediately at −80°C for subsequent gene expression analysis.”
BackgroundMethodInfluentialSelf-citationFine particulate matter inhibits phagocytosis of macrophages by disturbing autophagy
Li, Y., Yong, Y., Yang, M., Wang, W., Qu, X., Dang, X., Shang, D., Shao, Y., Liu, J., & Chang, Y. (2020) · The FASEB Journal · doi:10.1096/fj.202000657r · Cited by 32
Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency
Belchamber, K. B. R., Walker, E. M., Stockley, R. A., & Sapey, E. (2020) · International Journal of COPD · doi:10.2147/copd.s276792 · Cited by 29
Inhibition of LC3-associated phagocytosis in COPD and in response to cigarette smoke
Asare, P. F., Tran, H. B., Hurtado, P. R., Perkins, G. B., Nguyen, P., Jersmann, H. P. A., Roscioli, E., & Hodge, S. J. (2021) · Therapeutic Advances in Respiratory Disease · doi:10.1177/17534666211039769 · Cited by 28
Self-citationVascular endothelial growth factor enhances macrophage clearance of apoptotic cells
Kearns, M. T., Dalal, S., Horstmann, S. A., Richens, T. R., Tanaka, T., Doe, J. M., Boé, D. M., Voelkel, N. F., Taraseviciene‐Stewart, L., Janssen, W. J., et al. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00116.2011 · Cited by 29
“Alveolar macrophages (AMs) from patients with COPD are defective in their ability to clear apoptotic cells (16).”
The Involvement of Sphingolipids in Chronic Obstructive Pulmonary Diseases
Petrache, I., & Petrusca, D. N. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-7091-1511-4_12 · Cited by 28
Hodge, S. J., Dean, M. M., Hodge, G. L., Holmes, M., & Reynolds, P. N. (2011) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2011.01.710 · Cited by 28
Self-citationWrench, C., Belchamber, K. B. R., Bercusson, A., Shah, A., Barnes, P. J., Armstrong-James, D. P. H., & Donnelly, L. (2018) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2017-0351le · Cited by 28
What every clinician should know about inflammation in COPD
Wechsler, M. E., & Wells, J. M. (2024) · ERJ Open Research · doi:10.1183/23120541.00177-2024 · Cited by 29
Daidzein enhances efferocytosis via transglutaminase 2 and augmentation of Rac1 activity
Yen, J.-H., Yang, D., Chen, M.-C., Wu, Y., Hsieh, Y.-F., Cheng, Y.-M., Huang, W., Szondy, Z., & Tsay, G. J. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.04.006 · Cited by 27
Aerosolized vitamin E acetate causes oxidative injury in mice and in alveolar macrophages
Matsumoto, S., Traber, M. G., Leonard, S. W., Choi, J., Fang, X., Maishan, M., Wick, K. D., Jones, K. D., Calfee, C. S., Gotts, J. E., et al. (2022) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00482.2021 · Cited by 27
Increased lung neutrophil apoptosis and inflammation resolution in nonresponding pneumonia
Moret, I., Lorenzo, M.-J. J., Sarriá, B., Cases, E., Morcillo, E. J., Perpiñá, M., Molina, J. M., & Menéndez, R. (2011) · European Respiratory Journal · doi:10.1183/09031936.00190410 · Cited by 30
“The neutrophils amount and viability were determined using a trypan blue exclusion method[17, 18].”
MethodIntegrins and Small GTPases as Modulators of Phagocytosis
Sayedyahossein, S., & Dagnino, L. (2013) · International review of cytology · doi:10.1016/b978-0-12-407699-0.00006-6 · Cited by 27
Restoring cigarette smoke-induced impairment of efferocytosis in alveolar macrophages
Subramaniam, R., Mukherjee, S., Chen, H., Keshava, S., Neuenschwander, P. F., & Shams, H. (2015) · Mucosal Immunology · doi:10.1038/mi.2015.120 · Cited by 25
“Exposure to cigarette smoke changes the phenotype and function of AMs(8) and suppresses AMs’ efferocytosis activity.(6,7,18,19) Defective efferocytosis results in chronic inflammation and significantly increases the likelihood of developing chronic obstructive pulmonary disease, lung injury, and cancer.”
BackgroundDini, L., & Panzarini, E. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2010.010122 · Cited by 25
Mucci, A., Kunkiel, J., Suzuki, T., Brennig, S., Glage, S., Kühnel, M., Ackermann, M., Happle, C., Kuhn, A., Schambach, A., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.06.011 · Cited by 25
“…iPSC-M 4 may represent an innovative therapeutic option for other disease entities associated with malfunction of AMs such as chronic obstructive pulmonary disease (Hodge et al., 2003), bronchopulmonary dysplasia (Blackwell et al., 2011), or cystic fibrosis (Bruscia et al., 2009; Di et al., 2006).”
BackgroundPehote, G., Bodas, M., Brucia, K., & Vij, N. (2017) · Mediators of Inflammation · doi:10.1155/2017/3028082 · Cited by 25
“One plausible reason for this increase in mortality is an increased prevalence of cigarette smoking, which is one of the major risk factors for COPD pathogenesis [1, 4].”
BackgroundHelicobacter pylori Infection Inhibits Phagocyte Clearance of Apoptotic Gastric Epithelial Cells
Bimczok, D., Smythies, L. E., Waites, K. B., Grams, J. M., Stahl, R. D., Mannon, P., Peter, S., Wilcox, C. M., Harris, P. R., Das, S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203330 · Cited by 25
“disease (37), and cystic fibrosis (38).”
Animal Models of Chronic Obstructive Pulmonary Disease Exacerbations
Gaschler, G. J., Bauer, C. M. T., Zavitz, C. C. J., & mpfli, M. R. S. A. (2007) · KARGER eBooks · doi:10.1159/000107059 · Cited by 25
Statins as emerging treatments for asthma and chronic obstructive pulmonary disease
Walsh, G. M. (2008) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2.3.329 · Cited by 24
Immune and Genetic Mechanisms in COPD: Possible Targets for Therapeutic Interventions
Tzortzaki, E. G., Papi, A. A., Neofytou, E., Soulitzis, N., & Siafakas, N. M. (2013) · Current Drug Targets · doi:10.2174/1389450111314020002 · Cited by 24
An investigation of the resolution of inflammation (catabasis) in COPD
Noguera, A., Gómez, C., Faner, R., Cosío, B. G., González‐Périz, A., Clària, J., Carvajal, Á. F., & Agustí, A. G. N. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-101 · Cited by 24
“reported that the ability of alveolar macrophages to ingest apoptotic bronchial epithelial cells and neutrophils (efferocytosis) was reduced in COPD [14,15].”
BackgroundResultChen, A. C. –., Tran, H. B., Xi, Y., Yerkovich, S. T., Baines, K. J., Pizzutto, S. J., Carroll, M. L., Robertson, A. A. B., Cooper, M. A., Schroder, K., et al. (2018) · ERJ Open Research · doi:10.1183/23120541.00130-2017 · Cited by 24
Self-citationDehle, F. C., Mukaro, V. R., Jurisevic, C. A., Moffat, D. F. C., Ahern, J., Hodge, G. L., Jersmann, H. P. A., Reynolds, P. N., & Hodge, S. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061573 · Cited by 24
“Efferocytosis was investigated by flow cytometry as reported [4– 7] and detailed in Supporting Information S1.”
BackgroundMethodInfluentialSelf-citationLin, C., Li, Y., Lin, P., Wang, B., Lin, S., Huang, K., & Kor, C. (2022) · Scientific Reports · doi:10.1038/s41598-022-25520-8 · Cited by 23
Phagocytic clearance of apoptotic cells: role in lung disease
Yun, J. H., Henson, P. M., & Tuder, R. M. (2008) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2.6.753 · Cited by 23
Leaky lysosomes in lung transplant macrophages: azithromycin prevents oxidative damage
Persson, H. L., Vainikka, L. K., Sege, M., Wennerström, U., Dam-Larsen, S., & Persson, J. (2012) · Respiratory Research · doi:10.1186/1465-9921-13-83 · Cited by 23
“If the cell death is extensive, the lung macrophages often fail to phagocytose all of the apoptotic cells, and the resulting post-apoptotic necrosis may promote inflammation and fibrosis [10-12,15-19].”
BackgroundPatterns of Retention of Particulate Matter in Lung Tissues of Patients With COPD
Ling, S., McDonough, J. E., Gosselink, J. V., Elliott, W. M., Hayashi, S., Hogg, J. C., & van Eeden, S. F. (2011) · CHEST Journal · doi:10.1378/chest.10-2281 · Cited by 23
Wang, X., Zhang, D., Higham, A., Wolosianka, S., Gai, X., Zhou, L., Petersen, H. V., Pinto-Plata, V., Divo, M. J., Silverman, E. K., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-01446-5 · Cited by 22
Decrease of vascular endothelial growth factor in macrophages from long-term smokers
Nagai, K., Betsuyaku, T., Ito, Y., Nasuhara, Y., & Nishimura, M. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00110504 · Cited by 22
Increased CD8 T ‐cell granzyme B in COPD is suppressed by treatment with low‐dose azithromycin
Hodge, S. J., Hodge, G. L., Holmes, M., Jersmann, H. P. A., & Reynolds, P. N. (2014) · Respirology · doi:10.1111/resp.12415 · Cited by 21
Self-citationRajasinghe, L. D., Chauhan, P., Wierenga, K. A., Evered, A. O., Harris, S. N., Bates, M. A., Gavrilin, M. A., & Pestka, J. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02179 · Cited by 21
“Poor clearance and accumulation of dead cells has been extensively reported in diseases of chronic inflammation (76, 77) and autoimmunity (78–81), suggesting that effective efferocytosis of cell death corpses from multiple death mechanisms is essential for the maintenance of tissue homeostasis (27, 82).”
BackgroundIron-binding drugs targeted to lysosomes: a potential strategy to treat inflammatory lung disorders
Persson, H. L., & Richardson, D. R. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.8.997 · Cited by 21
“However, if the lung’s phagocytic clearance, which is mainly executed by alveolar macrophages (AMs), is impaired [4] or overwhelmed by extensive apoptosis, uncleared apoptotic bodies may undergo secondary necrosis and cause tissue damage [5,6].”
BackgroundLan, C., Yang, M., Su, W., Huang, K.-L., Lin, C.-C., Huang, Y.-C., Huang, C., Chen, H., Wu, C., Lee, C., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073365 · Cited by 20
“Such dysfunction contributes to persistent bacterial colonization, the accumulation of necrotic debris, and sustained airway inflammation [39].”
Recombinant Human Interferon Alpha 2b Prevents and Reverses Experimental Pulmonary Hypertension
Bauer, E. M., Zheng, H., Lotze, M. T., & Bauer, P. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096720 · Cited by 20
“Impaired efferocytosis is linked to the pathogenesis of chronic vascular and pulmonary inflammatory diseases including atherosclerosis [29], systemic lupus erythematosus, chronic obstructive pulmonary disease (COPD) [30,31], cystic fibrosis [32] and asthma [33,34].”
BackgroundTajbakhsh, A., Hayat, S. M. G., Mortazavi, D., Medhati, P., Rostami, B., Savardashtaki, A., & Momtazi‐Borojeni, A. A. (2021) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2021.1978419 · Cited by 20
“COPD smoker patients have greater efferocytosis deficiency [27].”
BackgroundHarrington, A. D., Smirnov, A., Tsirka, S. E., & Schoonen, M. A. A. (2014) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2014.07.002 · Cited by 19
“The concomitant disruption of efferocytosis (clearance of apoptotic cells via phagocytosis) creates a delayed “secondary” necrosis (Hodge et al., 2003; Oberdorster, 1995; Schmidt and Tuder, 2010).”
Reddy, A. T., Lakshmi, S. P., Muchumarri, R. R., & Reddy, R. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153336 · Cited by 20
“Such phagocytotic activity of AMs is reduced in COPD, thereby exacerbating pathogenesis [4].”
BackgroundMiR-344b-1-3p targets TLR2 and negatively regulates TLR2 signaling pathway
Xu, H. M., Wu, Y., Li, L., Yuan, W., Zhang, D., Yan, Q., Guo, Z., & Huang, W. (2017) · International Journal of COPD · doi:10.2147/copd.s120415 · Cited by 20
The immune system as a victim and aggressor in chronic obstructive pulmonary disease
McGrath, J. J. C., & Stämpfli, M. R. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.05.63 · Cited by 20
“For instance, cigarette smoke is well known to reduce the capacity of alveolar macrophages to perform phagocytosis (30), a process that is critically important to destroy pathogens that enter the lower airways, as well as facilitate the clearance of dead and dying cells.”
BackgroundEffects of Lipid Interactions on Model Vesicle Engulfment by Alveolar Macrophages
Justice, M. J., Petrusca, D. N., Rogozea, A. L., Williams, J. A., Schweitzer, K. S., Petrache, I., Wassall, S. R., & Petrache, H. I. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2013.12.036 · Cited by 19
Zhang, S., Xie, J., Su, B., Li, J. L., Hu, N., Chen, J., Luo, G., & Cui, T. (2015) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20154730 · Cited by 19
“Both an increase in the number of apoptotic cells and defective efferocytosis are involved in the pathogenesis of COPD (8-10).”
BackgroundTolerogenic signaling of alveolar macrophages induces lung adaptation to oxidative injury
Allard, B., Panariti, A., Pernet, E., Downey, J., Ano, S., Dembele, M., Nakada, E. M., Fujii, U., McGovern, T. K., Powell, W. S., et al. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.07.015 · Cited by 19
Tran, H. B., Hamon, R., Jersmann, H. P. A., Ween, M. P., Asare, P. F., Haberberger, R. V., Pant, H., & Hodge, S. J. (2021) · Journal of Inflammation · doi:10.1186/s12950-021-00286-4 · Cited by 19
Self-citationWeen, M. P., Ahern, J., Carroll, A., Hodge, G. L., Pizzutto, S. J., Jersmann, H. P. A., Reynolds, P. N., & Hodge, S. J. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.12.004 · Cited by 19
Self-citationImmune Dysregulation in Chronic Obstructive Pulmonary Disease
Pang, X., & Liu, X. (2024) · Immunological Investigations · doi:10.1080/08820139.2024.2334296 · Cited by 20
“…are increased in the small and large airways and peripheral blood, and lymphocyte apoptosis is increased in COPD patients (Baraldo, 2004; S. J. Hodge et al., 2003; Majo et al., 2001; Sales et al., 2017), the increased cytotoxicity of CD8+T lymphocytes and memory CD4+T lymphocytes in the…”
BackgroundLiu, A., Hong, P.-Y., Su, B., Wu, J.-H., & Chen, Z. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.02.022 · Cited by 18
Smoking and nonsmoking asthma: differences in clinical outcome and pathogenesis
Fattahi, F., Hylkema, M. N., Melgert, B. N., Timens, W., Postma, D. S., & ten Hacken, N. H. T. (2011) · Expert Review of Respiratory Medicine · doi:10.1586/ers.10.85 · Cited by 18
Liu, M., Shen, J., Yuan, H., Chen, F., Song, H., Qin, H., Li, Y., Xu, J., Ye, Q., Li, S., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26455 · Cited by 17
Yang, J., Qiao, M., Li, Y., Hu, G., Song, C., Xue, L., Bai, H., Yang, J., & Yang, X. (2018) · Mediators of Inflammation · doi:10.1155/2018/9031452 · Cited by 20
Red Blood Cell-Derived Iron Alters Macrophage Function in COPD
Baker, J. M., Hammond, M., Dungwa, J. V., Shah, R. D., Montero, Á., Higham, A., Lea, S., & Singh, D. (2021) · Biomedicines · doi:10.3390/biomedicines9121939 · Cited by 19
Back2Basics: animal lectins: an insight into a highly versatile recognition protein
Radhakrishnan, A., Chellapandian, H., Ramasamy, P., & Jeyachandran, S. (2022) · Journal of Proteins and Proteomics · doi:10.1007/s42485-022-00102-4 · Cited by 17
“Most of these receptors have been shown to mediate or control pathogen uptake, for example, phagocytosis of apoptotic cells in COPD (Hodge et al. 2003), this uptake is affected by various concerned factors.”
BackgroundRahman, M., Upadhyay, S., Ganguly, K., Introna, M., Ji, J., Boman, C., Muala, A., Blomberg, A., Sandström, T., & Palmberg, L. (2023) · Toxics · doi:10.3390/toxics11060532 · Cited by 17
“Despite an increased number of macrophages in COPD, asthma, and cystic fibrosis, macrophages have been suggested to be dysfunctional in those diseases, causing impaired phagocytosis [41,42].”
BackgroundPhagocytosis of dying cells: influence of smoking and static magnetic fields
Dini, L. (2010) · APOPTOSIS · doi:10.1007/s10495-010-0490-z · Cited by 17
Reference moist smokeless tobacco-induced apoptosis in human monocytes/macrophages cell line MM6
Lombard, C. A., Farthing, D. E., Sun, J., Fariss, M. W., & McKallip, R. J. (2010) · International Immunopharmacology · doi:10.1016/j.intimp.2010.06.002 · Cited by 17
Theprungsirikul, J., Skopelja‐Gardner, S., Burns, A. S., Wierzbicki, R. M., & Rigby, W. F. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.659523 · Cited by 17
“aeruginosa infection (10, 44), macrophages demonstrate significantly reduced phagocytic capacity of bacteria and apoptotic cells (42, 43, 45).”
BackgroundZhou, Q., Chen, Y., Liang, Y., & Sun, Y. (2024) · Metabolites · doi:10.3390/metabo14060317 · Cited by 16
“Moreover, the increased presence of apoptotic cells in the airways of COPD patients may stem from a deficiency in the ability of alveolar macrophages to phagocytize apoptotic cells, a process known as efferocytosis, particularly in COPD patients and current smokers [79].”
BackgroundEndogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation
Hernández, I., de la Rosa, J. V., Martin‐Rodríguez, P., Díaz-Sarmiento, M., Recio, C., Guerra, B., Fernández‐Pérez, L., León, T. E., Torres, R., Font-Díaz, J., et al. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05310-3 · Cited by 16
“…of esterified cholesterol shown by analysis of BALF and lung in LXR-DKO mice could be the result of overwhelmed foamy macrophages not being able to take up excess cholesterol from the extracellular medium, a function that is crucial for the role of AM in the homeostasis of surfactant material [7].”
BackgroundMethodExpression of Inflammatory Mediators in Induced Sputum: Comparative Study in Asthma and COPD
Paplińska‐Goryca, M., Nejman‐Gryz, P., Górska, K., Białek-Gosk, K., Hermanowicz-Salamon, J., & Krenke, R. (2016) · Advances in experimental medicine and biology · doi:10.1007/5584_2016_165 · Cited by 16
Rabelo, M. A. E., Lucinda, L. M. F., Reboredo, M. M., da Fonseca, L. M. C., dos Reis, F. F., Fazza, T. F., Brega, D. R., de Paoli, F., da Fonseca, A. D. S., & Pinheiro, B. V. (2017) · Inflammation · doi:10.1007/s10753-017-0675-5 · Cited by 16
Leukocyte Function in COPD: Clinical Relevance and Potential for Drug Therapy
Baker, J. R., & Donnelly, L. (2021) · International Journal of COPD · doi:10.2147/copd.s266394 · Cited by 20
Statins Enhance Clearance of Apoptotic Cells through Modulation of Rho-GTPases
Morimoto, K., Janssen, W. J., Fessler, M. B., Xiao, Y. Q., McPhillips, K. A., Borges, V. M., Kench, J. A., Henson, P. M., & Vandivier, R. W. (2006) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200603-073ms · Cited by 15
Movafagh, A., Ghanati, K., Amani, D., Mahdavi, S. M., Hashemi, M., Zare‐Abdollahi, D., Darvish, H., Gholami, M., HaghNejad, L., Mosammami, S., et al. (2013) · Archives of Advances in Biosciences · doi:10.22037/jps.v4i0.4037 · Cited by 14
Lee, Y., Song, J., Jeong, Y., Choi, E., Ahn, C. W., & Jang, W. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107685 · Cited by 14
Emerging drugs for bronchiectasis
Chang, A. B., Marsh, R. L., Smith‐Vaughan, H., & Hoffman, L. R. (2012) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2012.702755 · Cited by 14
“Hodge and colleagues identified an abnormal accumulation of epithelial cells undergoing apoptosis in the airways of adults with chronic inflammatory lung diseases including COPD and asthma [154,155].”
BackgroundProvost, K. A., Smith, M., Miller‐Larsson, A., Gudleski, G. D., & Sethi, S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0207675 · Cited by 13
Schivo, M., Albertson, T. E., Haczku, A., Kenyon, N. J., Zeki, A. A., Kuhn, B. T., Louie, S., & Avdalovic, M. V. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2016-000358 · Cited by 15
Perea, L., Rodrigo‐Troyano, A., Cantó, E., Domínguez‐Álvarez, M., Giner, J., Sánchez, F., Villar-García, J., Quero, S., García-Núñez, M., Marín, A., et al. (2020) · Respiratory Research · doi:10.1186/s12931-020-1278-5 · Cited by 13
Szondy, Z., Korponay-Szabo, I. R., Király, R., & Fésüs, L. (2011) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9781118105771.ch7 · Cited by 13
Kotnala, S., Kim, Y., Rajput, C., Reddy-Vari, H., Bolla, S., Marchetti, N. T., Kośmider, B., Bahmed, K., & Sajjan, U. S. (2021) · Clinical Science · doi:10.1042/cs20210099 · Cited by 12
Patterns and Underlying Mechanisms of Airway Epithelial Cell Death in COPD
Wang, T., Dong, Y., Fang, L., & Zhou, H. (2025) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2025.2542153 · Cited by 12
“In addition, increased oxidative stress and impaired efferocytosis lead to increased apoptosis and insufficient clearance of apoptotic cells [77,78].”
Wu, Y., Xu, H. M., Li, L., Yuan, W., Zhang, D., & Huang, W. (2016) · Inflammation · doi:10.1007/s10753-016-0363-x · Cited by 12
“AMs fromCOPD patients phagocytose fewer apoptotic epithelial cells comparedwith nonsmokers and smokers without COPD [17, 18].”
BackgroundPTX3 alleviates hard metal-induced acute lung injury through potentiating efferocytosis
Yan, W., Ma, D., Liu, Y., Sun, W., Cheng, D., Li, G., Zhou, S., Wang, Y., Wang, H., & Ni, C. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.113139 · Cited by 12
Metadata
- Authors
- Hodge, S., Hodge, G., Scicchitano, R., Reynolds, P. N., & Holmes, M.
- Affiliations
- Royal Adelaide Hospital (AU)
- Women's and Children's Hospital (AU)
- Venue
- Immunology & Cell Biology
- Publisher
- Wiley
- Published
- 2003-08
- Volume
- 81
- Issue
- 4
- Pages
- 289-296
- ISSN
- 0004-945X (ISSN-L)
- 0818-9641
- 1440-1711
- OpenAlex
- W1980191732
- Cited by
- 440
- References
- 32
- Citations by year
- 2026: 7 · 2025: 15 · 2024: 17 · 2023: 12 · 2022: 17 · 2021: 34 · 2020: 19 · 2019: 17 · 2018: 23 · 2017: 21 · 2016: 28 · 2015: 28 · 2014: 13 · 2013: 32 · 2012: 20
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Immunology and Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- Royal Adelaide Hospital
- Australian Lung Foundation
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- chronic obstructive pulmonary disease, alveolar macrophages, phagocytosis, cigarette smoke, 16HBE cells, MitoTracker Green, CD33, phagocytic defects
- MeSH terms
- Aged, Antibodies, Monoclonal, Bronchoalveolar Lavage Fluid, Cell Line, Transformed, Cell Survival, Epithelial Cells, Flow Cytometry, Humans, Phagocytosis, Macrophages, Alveolar, Apoptosis, Respiratory Mucosa, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review